Investing

Abbott Laboratories : ABT

ABT

Stock Data

$0.00

$0.00 (0.00%)

Asset Type

Common Stock

Exchange

NYSE

Currency

USD

Country

USA

Sector

HEALTHCARE

Industry

MEDICAL DEVICES

Abbott Laboratories is a global healthcare company with a broad portfolio of products across various segments, including pharmaceuticals, diagnostics, nutritional products, and medical devices. Founded in 1888 and headquartered in North Chicago, Illinois, Abbott is known for its innovative solutions in managing health conditions such as diabetes, cardiovascular diseases, and chronic pain. It also offers a range of diagnostics equipment and tests for infectious diseases, including HIV and influenza, as well as nutritional products for both pediatric and adult patients. Abbott's commitment to improving lives is evident through its diverse offerings aimed at enhancing health and well-being worldwide.

All Abbott Laboratories Articles

299 Articles

William Temple | Dec 8, 2025 at 8:21 AM EST

Lilly’s GLP-1 Surge Dwarfs Abbott’s Steady Device Growth With 54% Revenue Jump

Abbott Laboratories (NYSE: ABT) and Eli Lilly (NYSE: LLY) just reported Q3 earnings that highlight two fundamentally different healthcare bets.…

Lee Jackson | Nov 13, 2025 at 1:46 PM EST

Goldman Sachs Says US Stocks Could Lag for 10 Years: 5 Strong Buy Value Dividend Ideas

Here are five Goldman Sachs stock picks that conservative growth and income investors should consider moving to for what could…

Lee Jackson | Oct 26, 2025 at 12:25 PM EDT

Goldman Sachs Still Says Sell-Off Coming – 5 Safe Conviction List Picks

Founded in 1869, Goldman Sachs is the world’s second-largest investment bank by revenue and is ranked 55th on the Fortune…

Lee Jackson | Oct 17, 2025 at 9:13 AM EDT

Goldman Sachs 4 New Conviction List Stocks Offer Dividends and Growth

Here are the four new stock additions to the Goldman Sachs Conviction List for October—all outstanding total return ideas for…

Rich Duprey | Oct 14, 2025 at 9:29 AM EDT

I have invested in dividends for 11 years—These income machines pay me every quarter without a hitch

Over the past 11 years, I’ve built a portfolio centered on steady dividend payers, stocks that deliver reliable income quarter…

Lee Jackson | Oct 13, 2025 at 10:12 AM EDT

Worried Investors Should Look at the 5 Safest Dividend Kings Right Now

First, it was David Solomon from Goldman Sachs, then Jamie Dimon from J.P. Morgan, in less than a week, warning…

Joel South | Oct 10, 2025 at 1:44 PM EDT

Stock Market News October 10: S&P 500 (SPY) Falls 1.59% Before Earnings Kick-Off

The SPDR S&P 500 ETF (NYSEMKT: SPY) is down 1.59% at 1:45 PM ET as U.S.- China trade tensions are…

John Seetoo | Jul 28, 2025 at 1:38 PM EDT

3 Dividend Growth Stocks That Will Deliver Meaty Returns After 5 Years

It’s no secret that AI has captured the imagination of many growth oriented investors, which is a big reason why…

Eric Bleeker | Jul 17, 2025 at 6:45 AM EDT

Live: Abbott Labs (NYSE: ABT) Sinks 6% After Releasing Q2 Earnings

Abbott Laboratories (NYSE: ABT) is reporting before the market opens and we’ll be updating this article with live analysis.  So…

Lee Jackson | Jun 13, 2025 at 6:43 AM EDT

5 Dividend Kings Are Delivering Massive Total Returns of Up to 34% This Year

These five top Dividend Kings have posted massive double-digit total return figures so far this year and are Buy-rated by…

Lee Jackson | May 23, 2025 at 7:41 AM EDT

4 Dividend Aristocrats Are Absolutely Crushing the S&P 500 in 2025

These four Dividend Aristocrats are far outperforming the S&P 500 so far this year. They still offer investors good entry…

Lee Jackson | May 20, 2025 at 1:14 PM EDT

Stifel Has Big Second-Half Stock Market Concerns: 5 Defensive Value Dividend Stocks Buys

Stifel recommends “defensive value” stocks for the remainder of 2025, and the firm has these five rated Buy.

Gerelyn Terzo | Apr 16, 2025 at 10:55 AM EDT

S&P 500 (NYSEARCA: SPY) Live: JBHT (Nasdaq: JBHT) Falls, ABT (NYSE: ABT) Rises on Tariff Fallout

The markets remain stuck in the doldrums, owing to tariffs, but appear to be coming off their lows of the…

Trey Thoelcke | Nov 16, 2024 at 9:10 AM EST

Dividend King AbbVie Just Paid Investors: Here’s How Much They Got

AbbVie has rewarded shareholders again with a quarterly dividend. As a Dividend King, it is the epitome of a steady…

Rich Duprey | Aug 27, 2024 at 10:19 AM EDT

2 Stocks to Buy Now Before a Stock Market Crash

A recession is looming. Despite the S&P 500 nearing its all-time high, the yield curve inverted and the Sahm Rule…